ROCKET PHARMACEUTICALS, INC. - COM (RCKT)

Historical Portfolio Holders from Q1 2018 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
91.2M
Holdings value Q2 2024
$1.96B
Value change Q2 2024
-$32.1M
Grand Portfolio weight change Q2 2024
0%
Number of holders
174
Number of buys Q2 2024
92
Number of sells Q2 2024
-74
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 41.1K $759K +$423K $18.46 3
2024 Q2 91.2M $1.96B -$32.1M $21.53 177
2024 Q1 91.9M $2.48B +$108M $26.94 186
2023 Q4 89M $2.67B +$216K $29.97 194
2023 Q3 89.1M $1.83B +$251M $20.49 175
2023 Q2 76.3M $1.52B -$31.9M $19.87 161
2023 Q1 78.2M $1.34B +$44.8M $17.13 160
2022 Q4 75.9M $1.49B +$148M $19.57 165
2022 Q3 69.1M $1.1B +$65.7M $15.96 158
2022 Q2 64.5M $887M +$4.04M $13.76 140
2022 Q1 64.3M $1.02B +$10.5M $15.86 141
2021 Q4 63.1M $1.38B +$9.05M $21.83 140
2021 Q3 62M $1.85B -$24.6M $29.89 141
2021 Q2 61.8M $2.74B -$11M $44.29 146
2021 Q1 62M $2.75B -$22.9M $44.37 169
2020 Q4 61.9M $3.4B +$431M $54.84 171
2020 Q3 55.2M $1.26B +$20M $22.86 124
2020 Q2 53.3M $1.12B +$14.5M $20.93 114
2020 Q1 53.3M $744M +$12.2M $13.95 102
2019 Q4 51.7M $1.18B +$87.8M $22.76 118
2019 Q3 47.7M $555M -$32.6M $11.65 92
2019 Q2 49.1M $736M +$92.6M $15.00 96
2019 Q1 42.9M $751M +$16.3M $17.54 82
2018 Q4 42.1M $622M +$68.8M $14.82 86
2018 Q3 36.8M $906M +$70.6M $24.62 83
2018 Q2 31.1M $605M +$63.9M $19.63 76
2018 Q1 28M $502M +$502M $18.75 56